Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026

Go back to Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026
(NASDAQ: IPSC) Delayed: 1.85 --0 (-0%)
Previous Close $1.85    52 Week High
Open $1.85    52 Week Low
Day High $1.85    P/E N/A 
Day Low $1.85    EPS
Volume 20